Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study

• Asıl Yazarlar: Vera G. Kalugina (Yazar), Elena A. Vishneva (Yazar), Leyla S. Namazova-Baranova (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Union of pediatricians of Russia, 2020-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...